Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 199,878 | 193,520 | 205,449 | 209,361 | 188,000 |
| Cost of Goods | 89,586 | 76,274 | 77,071 | 80,190 | 79,616 |
| Gross Profit | 110,292 | 117,246 | 128,378 | 129,171 | 108,384 |
| Operating Expenses | 107,180 | 86,624 | 67,692 | 67,274 | 73,895 |
| Operating Income | 3,698 | 30,896 | 60,757 | 62,087 | 35,105 |
| Interest Expense | 19,519 | 15,862 | 19,292 | 21,767 | 20,463 |
| Other Income | 2,289 | 3,706 | -12,429 | 3,116 | 2,383 |
| Pre-tax Income | -13,532 | 18,740 | 29,036 | 43,436 | 17,025 |
| Income Tax | 1,519 | 4,244 | 12,073 | 11,929 | 5,042 |
| Net Income Continuous | -15,051 | 14,496 | 16,963 | 31,507 | 11,983 |
| Net Income | $-15,051 | $14,496 | $16,963 | $31,507 | $11,983 |
| EPS Basic Total Ops | -0.46 | 0.45 | 0.52 | 1.00 | 0.38 |
| EPS Basic Continuous Ops | -0.46 | 0.45 | 0.53 | 1.00 | 0.38 |
| EPS Diluted Total Ops | -0.46 | 0.40 | 0.48 | 0.84 | 0.34 |
| EPS Diluted Continuous Ops | -0.46 | 0.36 | 0.40 | 0.80 | 0.31 |
| EPS Diluted Before Non-Recurring Items | N/A | 1.50 | 1.85 | 2.06 | 1.47 |
| EBITDA(a) | $68,418 | $86,654 | $116,899 | $118,363 | $91,449 |